KRSNAA DIAGNOSTICS
|
KRSNAA DIAGNOSTICS Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | |
---|---|---|
Operational & Financial Ratios | ||
Earnings Per Share (Rs) | 19.78 | 21.78 |
CEPS(Rs) | 36.91 | 34.96 |
DPS(Rs) | 2.75 | 2.50 |
Book NAV/Share(Rs) | 234.43 | 217.33 |
Tax Rate(%) | 22.56 | 20.95 |
Margin Ratios | ||
Core EBITDA Margin(%) | 25.11 | 28.87 |
EBIT Margin(%) | 18.04 | 23.05 |
Pre Tax Margin(%) | 16.46 | 18.99 |
PAT Margin (%) | 12.75 | 15.02 |
Cash Profit Margin (%) | 23.79 | 24.10 |
Performance Ratios | ||
ROA(%) | 6.96 | 7.81 |
ROE(%) | 8.76 | 10.02 |
ROCE(%) | 11.75 | 14.47 |
Asset Turnover(x) | 0.55 | 0.52 |
Sales/Fixed Asset(x) | 0.87 | 0.93 |
Working Capital/Sales(x) | 3.85 | 2.14 |
Efficiency Ratios | ||
Fixed Capital/Sales(x) | 1.15 | 1.08 |
Receivable days | 49.07 | 46.38 |
Inventory Days | 12.83 | 7.35 |
Payable days | 343.02 | 467.93 |
Valuation Parameters | ||
PER(x) | 23.26 | 22.29 |
PCE(x) | 12.47 | 13.89 |
Price/Book(x) | 1.96 | 2.23 |
Yield(%) | 0.60 | 0.51 |
EV/Net Sales(x) | 2.81 | 2.91 |
EV/Core EBITDA(x) | 9.66 | 9.04 |
EV/EBIT(x) | 15.57 | 12.61 |
EV/CE(x) | 1.51 | 1.51 |
M Cap / Sales | 2.97 | 3.35 |
Growth Ratio | ||
Net Sales Growth(%) | 6.95 | - |
Core EBITDA Growth(%) | -3.22 | - |
EBIT Growth(%) | -16.29 | - |
PAT Growth(%) | -9.18 | - |
EPS Growth(%) | -9.18 | - |
Financial Stability Ratios | ||
Total Debt/Equity(x) | 0.04 | 0.06 |
Current Ratio(x) | 2.28 | 2.76 |
Quick Ratio(x) | 2.02 | 2.69 |
Interest Cover(x) | 11.42 | 5.68 |
Total Debt/Mcap(x) | 0.02 | 0.03 |
Compare Financial Ratios of peers of KRSNAA DIAGNOSTICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KRSNAA DIAGNOSTICS | ₹1,888.1 Cr | 3.6% | -7.4% | 17.1% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹86,400.2 Cr | -4% | -6.9% | 31.8% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹79,176.8 Cr | 1.5% | 0% | 77.6% | Stock Analytics | |
GLOBAL HEALTH | ₹37,886.4 Cr | -2.5% | 6.1% | 177% | Stock Analytics | |
FORTIS HEALTHCARE | ₹34,101.5 Cr | 1.8% | 5.5% | 69.1% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,542.0 Cr | -2% | -3.4% | 65.4% | Stock Analytics |
KRSNAA DIAGNOSTICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KRSNAA DIAGNOSTICS | 3.6% |
-7.4% |
17.1% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses